Past Events

SIP related events

Monday, 06th July 2020
The Summer Training Course for Young Patients Advocates (STYPA) – Leadership Programme is an exciting and unique opportunity offering a tailored high-quality training to young patient advocates or representatives, who have the motivation to learn more about advocacy and maximise their leadership potentials in a real environment. Our vision for STYPA is to create a platform where young patient advocates would empower, inspire, and learn from each other on an annual basis.
What is the topic?
This year’s topic will once again look at how patient advocacy is evolving and facing emerging challenges and opportunities, and the importance of keeping a strong ethical approach. Young patients’ voices are increasingly heard by regulatory bodies such as EMA, industry, HTA bodies, and policy makers, to ensure that their perspective is not missed to inform the decision-making process. As usual, these opportunities raise questions around the representativeness of those bringing the patient perspective, their potential conflict of interest or risk of bias depending on the role patient advocates play in which context. Through the training course, EPF will raise awareness among the new generation of young patient advocates on current challenges, obstacles, opportunities and will share good practises for ethical patient advocacy in complex Environments.
For further information, please visit the European Patients' Forum website.

STYPA 2020 - Shaping The Future of Patient Advocacy

The Summer Training Course for Young Patients Advocates (STYPA) – Leadership Programme is an exciting and unique opportunity offering a tailored hig…

Wednesday, 01st July 2020
On July 1st, the EFIC-Grunenthal Grant (E-G-G) will host a webinar on

Webinar "How to launch your career in pain research with the EFIC-Grunenthal Grant (E-G-G)"

On July 1st, the EFIC-Grunenthal Grant (E-G-G) will host a webinar on "How to launch your career in pain research with the EFIC-Grunenthal Grant (E-G-…

Tuesday, 30th June 2020
As a follow-up to the first EFNA webinar about the impact of Covid-19 on the future of neurology and advocacy in May, a second one will be hosted on June 30th. The topic of this EFNA Webinar will be

EFNA Webinar: Where's Neurology? Influencing Covid Recovery Planning, Programmes and Policies

As a follow-up to the first EFNA webinar about the impact of Covid-19 on the future of neurology and advocacy in May, a second one will be hosted on J…

Monday, 29th June 2020
Due to the latest developments regarding the COVID-19 outbreak this event has been updated to a virtual congress.
New and exciting times are dawning, with a slew of new therapies underway: CGRP antibodies for migraine prophylaxis, lasmiditan as an alternative to triptans for acute therapy, atogepant, ubrogepant, possibly PACAP antibodies and more. That is why “Head over Ache: Silver Lining Novel Treatments” is the motto of the 14th European Headache Federation Congress.
Physicians, psychologists, cost bearers, politicians, and those working in health care, must make sure that the new as well as the old treatments reach the right patients in the optimal way. Therefore doctors and scientists from Europe and abroad, but also EHF partners DMKG, DGS, EFIC, EMA, IHS and LTB are invited to take part in this event. 
Explore the future of headache treatment in the capital of Germany and visit the official website of the event for the programme and other information.

UPDATED: 14th European Headache Federation Congress

Due to the latest developments regarding the COVID-19 outbreak this event has been updated to a virtual congress. New and exciting times are dawning, …

Thursday, 25th June 2020
Due to the latest developments regarding the COVID-19 outbreak this event has been postponed. For further update or information about new dates, please visit the official congress website.
The first Joint European Chapters’ Congress took place, in 2018, in Nijmegen, The Netherlands and it attracted over 600 participants! That congress was organised with enthusiasm, under the supervision of Dr Mike De Jongste. It enabled amazing opportunities to interact with colleagues, with industry and with partners from all around the world, and to collaborate and discuss the vital issues involved in Neuromodulation in Europe.
Inspired by this concept, a tremendous scientific Programme has been prepared which includes everything you can expect from a premier neuromodulation meeting:

You will have the opportunity to discover plenary lectures from world experts, through “Pairs on the podium” style sessions: one giant from Europe and one giant from USA.


The congress will feature two pre-congress special events: a neuromodulation session specifically designed for, and by, nurses and its  first European cadaver course aimed at beginning neuromodulators.


The ability to showcase your own research through an innovative platform – from ePosters to a live-competition of abstract presentations – remains core to the congress.


This European Congress will take advantage of having all the chapters in the same place at the same time to host all regional chapters meetings on the pre-congress day. This great opportunity will allow to organise multinational common meetings mixing, once again, cultures, visions and dynamism.


During this congress, attendees will move forward to structure European registries, enlarge their research projects at a European level and capitalise on this energy to help our global community to grow and strengthen. 

This INS 2nd European Congress will offer you a unique chance to meet and network with a diverse, multidisciplinary international community of neuromodulation specialists, basic scientists, biomedical engineers, and members of the industry under the Paris summer lights.
For further Information and congress Programme, please visit the official website of the event.

POSTPONED: 2nd Joint Congress of the INS European Chapters 2020 (e-INS 2020)

Due to the latest developments regarding the COVID-19 outbreak this event has been postponed. For further update or information about new dates, pleas…

Wednesday, 24th June 2020









Save the date: The BMP Grant 2019-2020 Ceremony will be held on the 24th of June 2020 from 15h15 CEST (Brussels time) to 17h CEST in digital format.
The theme of the 2nd edition of the Brain, Mind and Pain Patient-Centred Innovation Grant is

Save the date: THE BMP GRANT 2019-2020 CEREMONY - Virtual event

Save the date: The BMP Grant 2019-2020 Ceremony will be held on the 24th of June 2020 from 15h15 CEST (Brussels time) to 17h CEST in digital …

Monday, 15th June 2020
This year’s course has been canceled in response to the coronavirus (COVID-19) pandemic. The next available course is in Boston, June 21-25, 2021. For further information and reimbursement procedure, please visit the official website of the event.
Updates and Practice Recommendations to Optimize the Assessment and Treatment of Pain
Headache, Fibromyalgia, Neuropathic, Myofascial, Cancer, Abdominal, Pelvic, Musculoskeletal, Spinal Pain
Relieving pain is one of the most challenging, yet important responsibilities in the practice of medicine. Whether we are addressing spinal, fibromyalgia, headache, abdominal, neuropathic, musculoskeletal or cancer pain, achieving optimal outcomes requires up-to-date treatment approaches.
In the past year alone, there have been significant changes in how we address pain related to these conditions. This program, Evaluating and Treating Pain, expediently and effectively ensures you are current with these changes and can incorporate them into practice to better assess pain complaints and develop an optimal course of action to relieve patient suffering. 
The evidence-based recommendations provided in this program cover:

Medications
Injection Therapies
Implantables
Acupuncture
Meditation
Surgery
Cognitive Therapy
Interventional Techniques
Complementary and Alternative Medicine

NEW STRATEGIES, GUIDELINES, AND UPDATES
Highlights of the 2020 program include:

Updates on the evaluation and treatment of pain: spinal, neuropathic, cancer, musculoskeletal, visceral, headache, fibromyalgia
State-of-the-art approaches to opioids:

How to recognize addiction
Alternatives to opioids
Weaning patients off of opioids
Patient selection
Dosing
Legal guidance for prescribing


Medical marijuana in clinical practice
Risk stratification, screening, and addiction psychopharmacology
Advances in pharmacologic treatments, injection therapies, and implanted devices
When and how to utilize acupuncture, mind/body interventions, and other complementary and alternative medicine techniques
Guidance for combining treatment options to assure adequate pain control
Techniques to improve examination and evaluation of the patient in pain: neurologic, musculoskeletal, psychosocial
Advances in complementary and alternative approaches to pain medicine
Interventional techniques for cancer patients
Measuring outcomes
Treating back pain: pathophysiology, imaging, interventional techniques, surgical management

For further information and course programme, please visit the official website of the event.

CANCELED: "Evaluating and Treating Pain" - Harvard Medical School Course

This year’s course has been canceled in response to the coronavirus (COVID-19) pandemic. The next available course is in Boston, June 21-25, 2021. F…

Friday, 12th June 2020
Due to the COVID-19 pandemic, this year's European Pain School has been rescheduled. Suitable replacement dates are being sought at the moment (the most likely period will be June 2021) and will be published on the official event website as soon as possible.
The European Pain School (EPS), founded at the University of Siena (Italy) in 2002, is the first and still the premier school intended for students working on basic science and clinical topics related to acute and chronic pain. EPS has an interdisciplinary perspective and a distinct research orientation in all fields of pain science and pain medicine.
The title of EPS 2020 is

POSTPONED: European Pain School (EPS) 2020 - University of Siena

Due to the COVID-19 pandemic, this year's European Pain School has been rescheduled. Suitable replacement dates are being sought at the moment (the mo…

Saturday, 06th June 2020

POSTPONED: Belgian Pain Society Annual Scientific Congress

"Chronic pain: primary, secondary & tertiary prevention" The annual Belgian Pain Society scientific congress has been postponed for December 5th in …

Wednesday, 03rd June 2020
Due to the current coronavirus pandemic, the EULAR President has decided to cancel the face-to-face annual congress in Frankfurt in June this year. However, the event will be transformed in a virtual congress experience. 
The annual EULAR Congress comprises the major event in the calendar of world rheumatology. In 2020, together will be brought physicians, scientists, patients of all ages and their families, health professionals and professionals representing the pharmaceutical industry, from across Europe and around the world. The main focus will be on the latest progress in the diverse array of EULAR, as well as the extraordinary advances in research.
As in previous years, EULAR Congress 2020 will address new treatments and strategies, as well as the impact, burden and cost of rheumatic musculoskeletal diseases for the individual and society a wide range of topics including innovation in population, health service, clinical, translational and basic science. Sessions dedicated to People with Arthritis and Rheumatism in Europe (PARE), Health Professionals in Rheumatology (HPR) will feature prominently. High quality health care industry sessions providing in-depth and focussed insights will again be offered. 
For further information and congress programme, please visit the official website of the event.

UPDATED: EULAR Annual Scientific Congress 2020

Due to the current coronavirus pandemic, the EULAR President has decided to cancel the face-to-face annual congress in Frankfurt in June this yea…

  1. Societal Impact of Pain (SIP)
  2. Events
  3. Calendar
  4. Past events
  • Register for the SIP Newsletter

    Stay informed about the most important events and news about the Societal Impact of Pain platform.

    subscribe now